Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pBluescript KS+mLT

Mouse lymphotoxin (TNF-beta) cDNA

Catalog number RDB01480
Resource name pBluescript KS+mLT
Alternative name Mouse lymphotoxin (TNF-beta) cDNA
Clone info. Mouse lymphotoxin (TNF-beta) cDNA. T3 promoter region on vector sequence may be deleted.
Vector backbone pBluescript KS (+) (Plasmid)
Size of vector backbone 3.0 kb
Selectable markers Amp^r
Gene/insert name Mouse lymphotoxin A (LT, TNF-beta) cDNA
Depositor|Developer Hamada, Hirofumi |
Other clones in our bank

External Database
Mouse lymphotoxin A (LT, TNF-beta)

          Reference sequence
            
           
          Remarks, protocol and/or map (gif) RDB01480.gif

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
          Ordering
          Order form [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          Please visit Information of Request for Distribution.[link] 
          提供案内 (日本国内) [open/close]

          提供条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。
          提供依頼
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]
          手続きの概要は、「提供申込みについて[link]」をご覧ください。

          Catalog # Resource name Shipping form Fee (non-profit org.)
          RDB01480 pBluescript KS+mLT DNA solution Please contact us.

          Please review the QC test results indicated by check icon below as well as clone information before placing your order.

          How to cite this biological resource

          Materials & Methods section:

          The pBluescript KS+mLT was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01480).

          Reference section:

          Further references such as user reports and related articles (go to bottom)


          Tips

          Featured content


          QC test results

          RIKEN BRC has sequenced portions of this material for quality test.
          Please review the QC test results indicated by check icon as well as clone information before placing your order.

          Test sheet RDB14248_A6Gdp1.pdf check

          Nucleotide sequence of a portion of this resource (if available).

          Primer: M13_-40
          Sequence file: RDB14248_A6Gda.seq check
          >01480_14248_A6Gd_M13(-40)_A01_01.ab1
              1 AAACGGGTAA TTGTAATACG ACTCACTATA GGGCGAATTG GAGCTCCACC GCGGTGGCGG
             61 CCGCTCTAGA ACTAGTGGAT CCTACAGTGC AAAGGCTCCA AAGAATACAC TGCTGGGGCT
            121 GAAGTGTAGA TGGGAGATGC CGTCGGTGTG GGTGGACAGC TGGTCTCCCT TACTGAGCAG
            181 GAACACAGCC CCCTGGTACA TTGAGCGCAC CCACGGTCCT TGAAGTCCCG GATACACAGA
            241 CTTCTGCGCA CTGAGGAGAG GCACATGGAA GGGGTATTGG GAGGAAAAGA GCTGGACCTC
            301 GTGTGCCAGG TAGATGGGAG TGGGAATGGC CCTGGGGGAG CAGCTTTCTC CAGAGAAAAC
            361 CACCTGGGAG TAGACAAAGT AGAGGCCACT GGTGGGGATC AGGAGGGAGT TGTTGCTCAA
            421 AGAGAAGCCA TGTCGGAGAA AGGCACGATC CGTGCTTGCT CTCCAGAGCA GTGAGTTCTG
            481 CTTGCTGGGG TACCCAACAA GGTGAGCAGC AGGTTTCAGG ATGCCATGGG TCAAGTGCTT
            541 CTGAGGGAGT GGATGGGCTG TCCTGGCAGC GGAGAAGCGG ACACCAGAGA GTCCCTGGGC
            601 CCCTAGAGGC AGGGCCAGCA GCAGCCCCAG GAGGAAGACA GGAGGGGTGC CAAGCACCCT
            661 CAAGAGGTGG AGACGGCCGA GCAGTGTCAT GGTGTCTAGA ATTCGCTTTC CAGTCGGGAA
            721 ACCTGTCGTG CCAGCTGCAT TAATGAATCG GCCAACGCGC GGGGAGAGGC GGTTTGCGTA
            781 TTGGGCGCTC TTCCGCTTCC TCGCTCACTG ACTCGCTGCG CTCGGTCGTT CGGCTGCGGC
            841 GAGCGGTATC AGCTCACTCA AAGGCGGTAA TACGGTTATC CACAGAATCA CGGGATAACG
            901 CAGGAAAGAA CATGTGAGCA AAAAGGCCAG CCAAAAGGCC AGGGAACCCG TAAAAAGGCC
            961 GCGTTTGCCT GGCCGTTTTT TCCATAGGCC TCCGCCCCCC CCTGACGAGC CATCACCAAA
           1021 AATCGACGCC TCCAAAGTCA AGAGGTGGCC GGAAACCCCG ACCAGGACCT ATAGGATACC
          1081 AGCCGCTTTC CCCCTTGGAA GGCCTCTTCG ATGACGACCT TCCATCCCCA TG
          //

          Please visit Sequencing and PCR primers for primer information.


          References

          Original, user report and related articles


          2023.08.18

          GNP_filter3_RDBDEP_html_230702.pl